AIDS Treatment News logo      

August 25, 2009

New Intelence Prescribing Information Warns of Severe Rash Risk

"The prescribing information for Intelence (etravirine) has been updated to reflect warnings of rare—but potentially life-threatening—skin reactions, including Stevens-Johnson syndrome. Systemic hypersensitivity reactions have also been reported and are characterized by rash, flulike symptoms and sometimes organ problems, including liver failure. "

Read more in POZ, August 24, 2009.